Skip to main content
Professionals
Capabilities
Insights
Locations
Our Firm
News
Events
Careers
search menu
Search
English (United Kingdom)
العربية
Deutsch
English
español
עברית
italiano
日本語
한국어
Nederlands
polski
português
中文
Search
submit search
{{typeahead}}
2006
Published Article
Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity
Capabilities
Life Sciences & Medical Technology
Offices
Boston
Share
John Buchanan co-authored an article in the
Journal of Medicinal Chemistry
titled "Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity."
You May Also Be Interested In:
July 25, 2024 - July 26, 2024
Event
ACI's 11th Annual Summit for Women Leaders in Life Sciences Law
Boston, United States
May 29, 2024 - May 30, 2024
Event
Yale Innovation Summit 2024
New Haven
March 28, 2024, 8:00 AM - 4:00 PM ET
Event
2024 Medtech Impact Symposium
Everett